Related Experiment Video
Updated: Feb 24, 2026

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
Published on: June 17, 2013
Nonmotor Subtyping in Parkinson's Disease
Anna Sauerbier1, Miguel Rosa-Grilo1, Mubasher A Qamar1
1Parkinson's Centre of Excellence, King's College Hospital Foundation Trust, London, United Kingdom; Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, United Kingdom.
Parkinson's disease subtypes are emerging, dominated by specific nonmotor symptoms. Understanding these nonmotor subtypes is key for developing personalized medicine approaches for Parkinson's disease patients.
Area of Science:
- Neurology
- Neuroscience
- Clinical Medicine
Background:
- Nonmotor symptoms are a core feature of Parkinson's disease (PD).
- Emerging evidence suggests distinct PD subtypes characterized by specific nonmotor symptom profiles.
- Subtyping PD is crucial for understanding disease heterogeneity and improving patient care.
Purpose of the Study:
- To summarize the rationale for nonmotor subtyping in Parkinson's disease.
- To present proposed nonmotor subgroups based on data-driven analysis and clinical data.
- To detail seven proposed clinical nonmotor subtypes, including presentation, biomarkers, and relevance.
Main Methods:
- Review of existing literature on nonmotor symptoms in Parkinson's disease.
- Data-driven cluster analysis to identify patient subgroups.
- Clinical observation and case studies to define subtypes.
Main Results:
- Identification of distinct nonmotor symptom clusters within the Parkinson's disease population.
- Proposal of seven clinically relevant nonmotor subtypes.
- Discussion of potential biomarkers and clinical significance for each subtype.
Conclusions:
- Nonmotor subtyping offers a framework for understanding Parkinson's disease heterogeneity.
- These subtypes have the potential to guide personalized treatment strategies.
- Future research should focus on validating these subtypes and their clinical utility for personalized medicine in Parkinson's disease.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Neural Regulation
Brainstem
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...

